Keyphrases
Dopamine Agonist
100%
Cabergoline
100%
Parkinson's Disease Treatment
100%
Levodopa
37%
Clinical Response
25%
Motor Score
25%
Carbidopa
25%
Anti-Parkinson
25%
Motor Fluctuations
25%
Mayo Clinic
12%
Tolerability
12%
Clinical Trials
12%
Parkinson's Disease
12%
Maximum Tolerated Dose
12%
Open-label Trial
12%
Rochester
12%
Once-daily
12%
Patients with Parkinson's Disease
12%
Idiopathic Parkinson's Disease
12%
Adverse Events
12%
Motor Control
12%
Maintenance Dose
12%
Dyskinesia
12%
Serial Assessment
12%
Stable Dose
12%
Diary Card
12%
High Dropout Rate
12%
Referral Center
12%
Motor Assessment
12%
Baseline Scores
12%
Agonist Drugs
12%
Pharmacology, Toxicology and Pharmaceutical Science
Dopamine Receptor Stimulating Agent
100%
Combination Therapy
100%
Parkinson's Disease
100%
Cabergoline
100%
Antiparkinson Agent
25%
Carbidopa Plus Levodopa
25%
Clinical Trial
12%
Tolerability
12%
Maintenance Dose
12%
Open-Label Trial
12%
Levodopa
12%
Adverse Event
12%
Dyskinesia
12%